Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection.

Pasikhova, Yanina; Morrison, Austin R; Katzman, Ju Hee; Syed, Misbahuddin

Pasikhova, Yanina; Morrison, Austin R; Katzman, Ju Hee; Syed, Misbahuddin.

Afiliação

Pasikhova Y; Department of Pharmacy Services, 25301Moffitt Cancer Center, Tampa, FL, USA.
Morrison AR; Department of Pharmacy Services, 25301Moffitt Cancer Center, Tampa, FL, USA.
Katzman JH; Department of Infectious Diseases, 7831University of South Florida, Tampa, FL, USA.
Syed M; Department of Infectious Diseases, 25301Moffitt Cancer Center, Tampa, FL, USA.

Cancer Control ; 29: 10732748211070720, 2022.

Article em En | MEDLINE | ID: mdl-35001670

Assuntos

Anticorpos Antivirais/imunologia; Vacinas contra COVID-19/administração & dosagem; Vacinas contra COVID-19/imunologia; COVID-19/prevenção & controle; Neoplasias Hematológicas/epidemiologia; Adulto; Idoso; Anticorpos Antivirais/análise; Humanos; Hospedeiro Imunocomprometido; Masculino; Pessoa de Meia-Idade; SARS-CoV-2

Palavras-chave

COVID-19; Hematologic Malignancies; anti-spike igG; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Vacinas contra COVID-19 / COVID-19 / Anticorpos Antivirais Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google